<html>
  <head>
    <title></title>
    <!-- Licensed to: Summit
         Document created using Broadridge PROfile 24.12.1.5274
         Copyright 1995 - 2024 Broadridge -->
  </head>
<body bgcolor="#ffffff" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: #000000;">
  <div style="text-align: center; font-weight: bold;">As filed with the Securities and Exchange Commission on December 19, 2024</div>
  <div>&#160;</div>
  <div style="text-align: right;">Registration No. 333-</div>
  <div>
    <div>&#160;
      <hr align="center" style="border: none; border-bottom: 1px solid black; border-top: 4px solid black; height: 10px; color: #ffffff; background-color: #ffffff; text-align: center; margin-left: auto; margin-right: auto;"></div>
  </div>
  <div style="text-align: center; font-size: 14pt; font-weight: bold;">UNITED STATES</div>
  <div style="text-align: center; font-size: 14pt; font-weight: bold;">SECURITIES AND EXCHANGE COMMISSION</div>
  <div style="text-align: center; font-size: 12pt; font-weight: bold;">Washington, D.C.&#160; 20549</div>
  <div>&#160;</div>
  <div style="text-align: center; font-size: 18pt; font-weight: bold;">FORM S-8</div>
  <div>&#160;</div>
  <div style="text-align: center; font-weight: bold;">REGISTRATION STATEMENT UNDER</div>
  <div style="text-align: center; font-weight: bold;">THE SECURITIES ACT OF 1933</div>
  <div>&#160;</div>
  <div style="text-align: center; font-size: 24pt; font-weight: bold;">Telix Pharmaceuticals Limited</div>
  <div style="text-align: center;">(Exact Name of Registrant as Specified in Its Charter)</div>
  <div>&#160;</div>
  <table cellspacing="0" cellpadding="0" border="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;" id="z0b37d3608c464b2ab97c90cd462ffcef">

      <tr>
        <td style="width: 49%; vertical-align: top; border-bottom: 2px solid rgb(0, 0, 0);">
          <div style="text-align: center; font-weight: bold;">Australia</div>
        </td>
        <td style="width: 2%; vertical-align: top;"><br>
        </td>
        <td style="width: 49%; vertical-align: top; border-bottom: 2px solid rgb(0, 0, 0);">
          <div style="text-align: center; font-weight: bold;">Not Applicable</div>
        </td>
      </tr>
      <tr>
        <td style="width: 49%; vertical-align: bottom;">
          <div style="text-align: center;">(State or Other Jurisdiction of Incorporation or Organization)</div>
        </td>
        <td style="width: 2%; vertical-align: top;"><br>
        </td>
        <td style="width: 49%; vertical-align: top;">
          <div style="text-align: center;">(I.R.S. Employer Identification No.)</div>
        </td>
      </tr>

  </table>
  <div><br>
  </div>
  <table cellspacing="0" cellpadding="0" border="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;" id="zbd3fd530a24e40fcb5ac8b609c5956c1">

      <tr>
        <td style="width: 49%; vertical-align: top; border-bottom: 2px solid rgb(0, 0, 0);">
          <div style="text-align: center; font-weight: bold;">Telix Pharmaceuticals Limited</div>
          <div style="text-align: center; font-weight: bold;">55 Flemington Road</div>
          <div style="text-align: center; font-weight: bold;">North Melbourne, Victoria, 3051, Australia</div>
        </td>
        <td style="width: 2%; vertical-align: top;"><br>
        </td>
        <td style="width: 49%; vertical-align: top; border-bottom: 2px solid rgb(0, 0, 0);">
          <div>&#160;</div>
          <div>&#160;</div>
          <div style="text-align: center; font-weight: bold;">Not Applicable</div>
        </td>
      </tr>
      <tr>
        <td style="width: 49%; vertical-align: top;">
          <div style="text-align: center;">(Address of Principal Executive Offices)</div>
        </td>
        <td style="width: 2%; vertical-align: top;"><br>
        </td>
        <td style="width: 49%; vertical-align: top;">
          <div style="text-align: center;">(Zip Code)</div>
        </td>
      </tr>

  </table>
  <div style="text-align: center; font-weight: bold;"> <br>
  </div>
  <div style="text-align: center; font-weight: bold;">Equity Incentive Plan Rules</div>
  <div style="text-align: center; font-weight: bold;">Telix Pharmaceuticals (US) Inc. Employee Stock Purchase Plan Rules</div>
  <div style="text-align: center;">(Full Title of the Plan)</div>
  <div>&#160;</div>
  <div style="text-align: center; font-weight: bold;">Telix Pharmaceuticals (US) Inc.</div>
  <div style="text-align: center; font-weight: bold;">11700 Exit 5 Pkwy, Suite 200</div>
  <div style="text-align: center; font-weight: bold;">Fishers, Indiana 46037</div>
  <div style="text-align: center; font-weight: bold;">Tel: (317) 588-9700</div>
  <div style="text-align: center;">(Name, address, including zip code, and telephone number, including area code, of agent for service)</div>
  <div><br>
  </div>
  <div>Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, smaller reporting company, or an emerging growth company. See the definitions of &#8220;large accelerated filer,&#8221; &#8220;accelerated
    filer,&#8221; &#8220;smaller reporting company,&#8221; and &#8220;emerging growth company&#8221; in Rule 12b-2 of the Exchange Act.</div>
  <div>&#160;</div>
  <table cellspacing="0" cellpadding="0" border="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: rgb(0, 0, 0);" id="zff61d84572744f0da8f7106ddd6fda30">

      <tr>
        <td style="width: 50%; vertical-align: top;">
          <div>Large accelerated filer&#160; &#9744;</div>
        </td>
        <td style="width: 50%; vertical-align: top;">
          <div>Accelerated filer&#160; &#9744;</div>
        </td>
      </tr>
      <tr>
        <td style="width: 50%; vertical-align: top;" rowspan="1">&#160;</td>
        <td style="width: 50%; vertical-align: top;" rowspan="1">&#160;</td>
      </tr>
      <tr>
        <td style="width: 50%; vertical-align: top;">
          <div>Non-accelerated filer&#160; &#9746;</div>
        </td>
        <td style="width: 50%; vertical-align: top;">
          <div>Smaller reporting company &#9744;</div>
        </td>
      </tr>
      <tr>
        <td style="width: 50%; vertical-align: top;"><br>
        </td>
        <td style="width: 50%; vertical-align: top;">&#160;</td>
      </tr>
      <tr>
        <td style="width: 50%; vertical-align: top;"><br>
        </td>
        <td style="width: 50%; vertical-align: top;">
          <div>Emerging growth company&#160; &#9746;</div>
        </td>
      </tr>

  </table>
  <div> <br>
  </div>
  <div>If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 7(a)(2)(B) of the
    Securities Act. &#9744;</div>
  <div>&#160;</div>
  <div>
    <hr align="center" style="border: none; border-bottom: 4px solid black; border-top: 1px solid black; height: 10px; color: #ffffff; background-color: #ffffff; text-align: center; margin-left: auto; margin-right: auto;"></div>
  <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
    <div style="page-break-after: always;" class="BRPFPageBreak">
      <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
  </div>
  <div style="text-align: center; font-weight: bold;">PART I</div>
  <div>&#160;</div>
  <div style="text-align: center; font-weight: bold;">INFORMATION REQUIRED IN THE SECTION 10(a) PROSPECTUS</div>
  <div>&#160;</div>
  <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="zd479798d02d64f149a86b58742e2e077">

      <tr>
        <td style="width: 36pt;">&#160;</td>
        <td style="width: 36pt; vertical-align: top; font-weight: bold;">Item 1.</td>
        <td style="width: auto; vertical-align: top;">
          <div style="font-weight: bold;">Plan Information.</div>
        </td>
      </tr>

  </table>
  <div>&#160;</div>
  <div style="text-indent: 36pt;">The information required by Item 1 is included in documents sent or given to participants in the plans covered by this registration statement pursuant to Rule 428(b)(1) of the Securities Act of 1933, as amended (the
    &#8220;Securities Act&#8221;).</div>
  <div>&#160;</div>
  <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="zf5fdeac688864ce1a90686349434662c">

      <tr>
        <td style="width: 36pt;"><br>
        </td>
        <td style="width: 36pt; vertical-align: top; font-weight: bold;">Item 2.</td>
        <td style="width: auto; vertical-align: top;">
          <div style="font-weight: bold;">Registrant Information and Employee Plan Annual Information.</div>
        </td>
      </tr>

  </table>
  <div>&#160;</div>
  <div style="text-indent: 36pt;">The written statement required by Item 2 is included in documents sent or given to participants in the plans covered by this registration statement pursuant to Rule 428(b)(1) of the Securities Act.</div>
  <div>&#160;</div>
  <div style="text-align: center; font-weight: bold;">PART II</div>
  <div>&#160;</div>
  <div style="text-align: center; font-weight: bold;">INFORMATION REQUIRED IN THE REGISTRATION STATEMENT</div>
  <div>&#160;</div>
  <div>
    <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable">

        <tr>
          <td style="width: 36pt;"><br>
          </td>
          <td style="width: 36pt; vertical-align: top; font-weight: bold;">Item 3.</td>
          <td style="width: auto; vertical-align: top;"><font style="font-weight: bold;">Incorporation of Documents by Reference.</font></td>
        </tr>

    </table>
  </div>
  <div> <br>
  </div>
  <div style="text-indent: 36pt;">The Registrant is subject to the informational and reporting requirements of Sections 13(a), 14, and 15(d) of the Securities Exchange Act of 1934, as amended (the &#8220;Exchange Act&#8221;) applicable to foreign private issuers, and
    in accordance therewith files reports and other information with the Securities and Exchange Commission (the &#8220;Commission&#8221;).&#160; The following documents, which are on file with the Commission, are incorporated in this registration statement (&#8220;Registration
    Statement&#8221;) by reference:</div>
  <div>&#160;</div>
  <div style="text-indent: 36pt;">(a)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;The Registrant&#8217;s effective registration statement on Form 20-F filed pursuant to Section 12 of the Exchange Act on <a href="https://www.sec.gov/Archives/edgar/data/2007191/000114036124044557/ny20034211x5_20fr12ba.htm">October 30, 2024</a> (File No. 001-42128), which contains the registrant&#8217;s audited financial statements for the latest fiscal year for which such
    statements have been filed.</div>
  <div>&#160;</div>
  <div style="text-indent: 36pt;">(b)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;The description of the ordinary shares, no par value, and American Depositary Shares, each representing one ordinary share, no par value, contained in the Registrant&#8217;s registration statement on Form 20-F filed
    pursuant to Section 12 of the Exchange Act on <a href="https://www.sec.gov/Archives/edgar/data/2007191/000114036124044557/ny20034211x5_20fr12ba.htm">October 30, 2024</a> (File No. 001-42128), including any amendment or report filed for the purpose of
    updating such description.</div>
  <div>&#160;</div>
  <div style="text-indent: 36pt;">All documents subsequently filed by the Registrant pursuant to Sections 13(a), 13(c), 14 or 15(d) of the Exchange Act, prior to the filing of a post-effective amendment which indicates that all securities offered hereby
    have been sold or which deregisters all securities then remaining unsold, shall be deemed to be incorporated by reference in this Registration Statement and to be part hereof from the date of the filing of such documents.</div>
  <div>&#160;</div>
  <div style="text-indent: 36pt;">Any statement contained in a document incorporated or deemed to be incorporated by reference herein shall be deemed to be modified or superseded for the purposes of this Registration Statement to the extent that a
    statement contained herein or in any other subsequently filed document which also is or is deemed to be incorporated by reference herein modifies or supersedes such statement.&#160; Any statement so modified or superseded shall not be deemed, except as so
    modified or superseded, to constitute a part of this Registration Statement.</div>
  <div>&#160;</div>
  <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="ze56f86e6333f4adf9a1a825683cae64b">

      <tr>
        <td style="width: 36pt;"><br>
        </td>
        <td style="width: 36pt; vertical-align: top; font-weight: bold;">Item 4.</td>
        <td style="width: auto; vertical-align: top;">
          <div style="font-weight: bold;">Description of Securities.</div>
        </td>
      </tr>

  </table>
  <div>&#160;</div>
  <div style="text-indent: 36pt;">Not applicable.</div>
  <div>&#160;</div>
  <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z64277041267847d3af5e4591481828a3">

      <tr>
        <td style="width: 36pt;"><br>
        </td>
        <td style="width: 36pt; vertical-align: top; font-weight: bold;">Item 5.</td>
        <td style="width: auto; vertical-align: top;">
          <div style="font-weight: bold;">Interests of Named Experts and Counsel.</div>
        </td>
      </tr>

  </table>
  <div>&#160;</div>
  <div style="text-indent: 36pt;">Not applicable.</div>
  <div style="text-indent: 36pt;"> <br>
  </div>
  <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
    <div style="page-break-after: always;" class="BRPFPageBreak">
      <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
  </div>
  <div>
    <table cellspacing="0" cellpadding="0" class="DSPFListTable" id="z0f5d0104e72f4ddca4ccc31d56f64ef5" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%;">

        <tr style="vertical-align: top;">
          <td style="width: 36pt;">&#160;</td>
          <td style="text-align: right; vertical-align: top; width: 36pt;">
            <div style="color: rgb(0, 0, 0); text-align: left; font-weight: bold;">Item 6.</div>
          </td>
          <td style="text-align: left; vertical-align: top; width: auto;">
            <div style="color: rgb(0, 0, 0); font-weight: bold;">Indemnification of Directors and Officers.</div>
          </td>
        </tr>

    </table>
  </div>
  <div style="text-indent: 36pt; color: #000000;"><font style="font-style: italic;"> <br>
    </font></div>
  <div style="text-indent: 36pt; color: #000000;"><font style="font-style: italic;">Australian law</font>. Australian law provides that a company or a related body corporate of the company may provide for indemnification of officers and directors, except
    to the extent of any of the following liabilities incurred as an officer or director of the company:</div>
  <div>&#160;</div>
  <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z0460e7b973a74498b0052f8d1ddcdb4d">

      <tr>
        <td style="width: 36pt;"><br>
        </td>
        <td style="width: 19pt; vertical-align: top; color: rgb(0, 0, 0);">&#8226;</td>
        <td style="width: auto; vertical-align: top;">
          <div style="color: rgb(0, 0, 0);">a liability owed to the company or a related body corporate of the company&#894;</div>
        </td>
      </tr>

  </table>
  <div>&#160;</div>
  <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z3158795ba70240f6a39afa13b5a0b1e5">

      <tr>
        <td style="width: 36pt;"><br>
        </td>
        <td style="width: 19pt; vertical-align: top; color: rgb(0, 0, 0);">&#8226;</td>
        <td style="width: auto; vertical-align: top;">
          <div style="color: rgb(0, 0, 0);">a liability for a pecuniary penalty order made under section 1317G or a compensation order under section 961M, 1317H, 1317HA, 1317HB, 1317HC or 1317HE of the Australian Corporations Act&#894;</div>
        </td>
      </tr>

  </table>
  <div>&#160;</div>
  <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z2387bc18d62e4d569a203e116f26450f">

      <tr>
        <td style="width: 36pt;"><br>
        </td>
        <td style="width: 19pt; vertical-align: top; color: rgb(0, 0, 0);">&#8226;</td>
        <td style="width: auto; vertical-align: top;">
          <div style="color: rgb(0, 0, 0);">a liability that is owed to someone other than the company or a related body corporate of the company and did not arise out of conduct in good faith&#894; or</div>
        </td>
      </tr>

  </table>
  <div>&#160;</div>
  <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z86f431254dd3457f9b2c20fd1e1c667e">

      <tr>
        <td style="width: 36pt;"><br>
        </td>
        <td style="width: 19pt; vertical-align: top; color: rgb(0, 0, 0);">&#8226;</td>
        <td style="width: auto; vertical-align: top;">
          <div style="color: rgb(0, 0, 0);">legal costs incurred in defending an action for a liability incurred as an officer or director of the company if the costs are incurred:</div>
        </td>
      </tr>

  </table>
  <div>&#160;</div>
  <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z4f0a174162fe4089aad7aa15761f2496">

      <tr>
        <td style="width: 56pt;"><br>
        </td>
        <td style="width: 16pt; vertical-align: top; color: rgb(0, 0, 0);">&#9675;</td>
        <td style="width: auto; vertical-align: top;">
          <div style="color: rgb(0, 0, 0);">in defending or resisting proceedings in which the person is found to have a liability for which they cannot be indemnified as set out above&#894;</div>
        </td>
      </tr>

  </table>
  <div>&#160;</div>
  <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z61853b14bdd341ccb4c0937a982617da">

      <tr>
        <td style="width: 56pt;"><br>
        </td>
        <td style="width: 16pt; vertical-align: top; color: rgb(0, 0, 0);">&#9675;</td>
        <td style="width: auto; vertical-align: top;">
          <div style="color: rgb(0, 0, 0);">in defending or resisting criminal proceedings in which the person is found guilty&#894;</div>
        </td>
      </tr>

  </table>
  <div>&#160;</div>
  <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="zd45ff632898e434fbab0a1e6c005ea6a">

      <tr>
        <td style="width: 56pt;"><br>
        </td>
        <td style="width: 16pt; vertical-align: top; color: rgb(0, 0, 0);">&#9675;</td>
        <td style="width: auto; vertical-align: top;">
          <div style="color: rgb(0, 0, 0);">in defending or resisting proceedings brought by the Australian Securities &amp; Investments Commission or a liquidator for a court order if the grounds for making the order are found by the court to have been
            established (except costs incurred in responding to actions taken by the Australian Securities &amp; Investments Commission or a liquidator as part of an investigation before commencing proceedings for the court order)&#894; or</div>
        </td>
      </tr>

  </table>
  <div>&#160;</div>
  <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z8ce93e2a49ce4992b67b037cd52b6af8">

      <tr>
        <td style="width: 56pt;"><br>
        </td>
        <td style="width: 16pt; vertical-align: top; color: rgb(0, 0, 0);">&#9675;</td>
        <td style="width: auto; vertical-align: top;">
          <div style="color: rgb(0, 0, 0);">in connection with proceedings for relief to the person under the Australian Corporations Act, in which the court denies the relief.</div>
        </td>
      </tr>

  </table>
  <div><br>
  </div>
  <div style="text-indent: 36pt;"><font style="font-style: italic; color: rgb(0, 0, 0);">Constitution</font><font style="color: rgb(0, 0, 0);">. The Registrant&#8217;s Constitution provides that, except to the extent prohibited by the law including under the
      Australian Corporations Act, the Registrant must indemnify every person who is or has been a director, alternate director or executive officer of the </font>Registrant <font style="color: rgb(0, 0, 0);">and such other officers or former officers of
      the </font>Registrant <font style="color: rgb(0, 0, 0);">or of its related bodies corporate as the board of directors in each case determines against all losses, liabilities, costs, charges and expenses incurred by that person as an officer.</font></div>
  <div><br>
  </div>
  <div style="text-indent: 36pt; color: #000000;"><font style="font-style: italic;">Indemnification and Insurance Agreements</font>. Pursuant to Deeds of Access, Insurance and Indemnity, the Registrant has agreed to indemnify the Registrant&#8217;s executive
    officers and non-employee directors against certain liabilities and expenses incurred by such persons in connection with claims made by reason of their being such a director or officer. The Registrant also maintains insurance policies that indemnify
    the Registrant&#8217;s directors and executive officers against various liabilities arising under the Securities Act or the Exchange Act, that might be incurred by any director or officer in his or her capacity as such. The underwriters are obligated, under
    certain circumstances, pursuant to the underwriting agreement, to indemnify the Registrant, the Registrant&#8217;s officers and the Registrant&#8217;s directors against liabilities under the Securities Act.</div>
  <div><br>
  </div>
  <div style="text-indent: 36pt; color: #000000;"><font style="font-style: italic;">SEC Position</font>. Insofar as indemnification for liabilities arising under the Securities Act may be permitted to directors, officers or persons controlling the
    Registrant pursuant to the foregoing provisions, the Registrant has been informed that in the opinion of the SEC such indemnification is against public policy as expressed in the Securities Act and is therefore unenforceable.</div>
  <div><br>
  </div>
  <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="za149bb108a0949ad866ef71807a1f154">

      <tr>
        <td style="width: 36pt;"><br>
        </td>
        <td style="width: 36pt; vertical-align: top; font-weight: bold;">Item 7.</td>
        <td style="width: auto; vertical-align: top;">
          <div style="font-weight: bold;">Exemption from Registration Claimed.</div>
        </td>
      </tr>

  </table>
  <div>&#160;</div>
  <div style="text-indent: 36pt;">Not applicable.</div>
  <div>&#160;</div>
  <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
    <div style="page-break-after: always;" class="BRPFPageBreak">
      <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
  </div>
  <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z316b498a261944b5b550eeb2a90fdceb">

      <tr>
        <td style="width: 36pt;"><br>
        </td>
        <td style="width: 36pt; vertical-align: top; font-weight: bold;">Item 8.</td>
        <td style="width: auto; vertical-align: top;">
          <div style="font-weight: bold;">Exhibits.</div>
        </td>
      </tr>

  </table>
  <div>&#160;</div>
  <table cellspacing="0" cellpadding="0" border="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;" id="z98055b56cb2749659008ffa174f23625">

      <tr>
        <td style="width: 10%; vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0);">
          <div style="font-weight: bold;">Number</div>
        </td>
        <td style="width: 2%; vertical-align: bottom;">&#160;</td>
        <td style="width: 88%; vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0);">
          <div style="font-weight: bold;">Description</div>
        </td>
      </tr>
      <tr>
        <td style="width: 10%; vertical-align: top; background-color: rgb(204, 238, 255);">
          <div><a href="https://www.sec.gov/Archives/edgar/data/2007191/000114036124043618/ny20034211x3_ex1-2.htm">4.1</a></div>
        </td>
        <td style="width: 2%; vertical-align: top; background-color: rgb(204, 238, 255);">&#160;</td>
        <td style="width: 88%; vertical-align: top; background-color: rgb(204, 238, 255);">
          <div>Constitution of the Registrant (incorporated herein by reference to Exhibit 1.2 to the Registrant&#8217;s Registration Statement on Form 20-F, filed on October 30, 2024 (File No. 001-42128)).</div>
        </td>
      </tr>
      <tr>
        <td style="width: 10%; vertical-align: top;" rowspan="1">&#160;</td>
        <td style="width: 2%; vertical-align: top;" rowspan="1">&#160;</td>
        <td style="width: 88%; vertical-align: top;" rowspan="1">&#160;</td>
      </tr>
      <tr>
        <td style="width: 10%; vertical-align: top; background-color: rgb(204, 238, 255);">
          <div><a href="https://www.sec.gov/Archives/edgar/data/2007191/000114036124043618/ny20034211x3_ex2-1.htm">4.2</a></div>
        </td>
        <td style="width: 2%; vertical-align: top; background-color: rgb(204, 238, 255);">&#160;</td>
        <td style="width: 88%; vertical-align: top; background-color: rgb(204, 238, 255);">
          <div>Deposit Agreement among the Registrant, JPMorgan Chase Bank, N.A., as depositary, and all Holders and Beneficial Owners of American depositary receipts issued thereunder (incorporated herein by reference to Exhibit 2.1 to the Registrant&#8217;s
            Registration Statement on Form 20-F, filed on October 30, 2024 (File No. 001-42128)).</div>
        </td>
      </tr>
      <tr>
        <td style="width: 10%; vertical-align: top;" rowspan="1">&#160;</td>
        <td style="width: 2%; vertical-align: top;" rowspan="1">&#160;</td>
        <td style="width: 88%; vertical-align: top;" rowspan="1">&#160;</td>
      </tr>
      <tr>
        <td style="width: 10%; vertical-align: top; background-color: rgb(204, 238, 255);">
          <div><a href="ef20040301_ex5-1.htm">5.1*</a></div>
        </td>
        <td style="width: 2%; vertical-align: top; background-color: rgb(204, 238, 255);">&#160;</td>
        <td style="width: 88%; vertical-align: top; background-color: rgb(204, 238, 255);">
          <div>Opinion of Herbert Smith Freehills.</div>
        </td>
      </tr>
      <tr>
        <td style="width: 10%; vertical-align: top;" rowspan="1">&#160;</td>
        <td style="width: 2%; vertical-align: top;" rowspan="1">&#160;</td>
        <td style="width: 88%; vertical-align: top;" rowspan="1">&#160;</td>
      </tr>
      <tr>
        <td style="width: 10%; vertical-align: top; background-color: rgb(204, 238, 255);">
          <div><a href="ef20040301_ex23-1.htm">23.1*</a></div>
        </td>
        <td style="width: 2%; vertical-align: top; background-color: rgb(204, 238, 255);">&#160;</td>
        <td style="width: 88%; vertical-align: top; background-color: rgb(204, 238, 255);">
          <div>Consent of PricewaterhouseCoopers.</div>
        </td>
      </tr>
      <tr>
        <td style="width: 10%; vertical-align: top;" rowspan="1">&#160;</td>
        <td style="width: 2%; vertical-align: top;" rowspan="1">&#160;</td>
        <td style="width: 88%; vertical-align: top;" rowspan="1">&#160;</td>
      </tr>
      <tr>
        <td style="width: 10%; vertical-align: top; background-color: rgb(204, 238, 255);">
          <div><a href="ef20040301_ex5-1.htm">23.2*</a></div>
        </td>
        <td style="width: 2%; vertical-align: top; background-color: rgb(204, 238, 255);">&#160;</td>
        <td style="width: 88%; vertical-align: top; background-color: rgb(204, 238, 255);">
          <div>Consent of Herbert Smith Freehills (included in Exhibit 5.1).</div>
        </td>
      </tr>
      <tr>
        <td style="width: 10%; vertical-align: top;" rowspan="1">&#160;</td>
        <td style="width: 2%; vertical-align: top;" rowspan="1">&#160;</td>
        <td style="width: 88%; vertical-align: top;" rowspan="1">&#160;</td>
      </tr>
      <tr>
        <td style="width: 10%; vertical-align: top; background-color: rgb(204, 238, 255);">
          <div><a href="#POWERSOFATTORNEYANDSIGNAT">24.1*</a></div>
        </td>
        <td style="width: 2%; vertical-align: top; background-color: rgb(204, 238, 255);">&#160;</td>
        <td style="width: 88%; vertical-align: top; background-color: rgb(204, 238, 255);">
          <div>Power of Attorney (included on the signature pages of this registration statement).</div>
        </td>
      </tr>
      <tr>
        <td style="width: 10%; vertical-align: top;" rowspan="1">&#160;</td>
        <td style="width: 2%; vertical-align: top;" rowspan="1">&#160;</td>
        <td style="width: 88%; vertical-align: top;" rowspan="1">&#160;</td>
      </tr>
      <tr>
        <td style="width: 10%; vertical-align: top; background-color: rgb(204, 238, 255);">
          <div><a href="ef20040301_ex99-1.htm">99.1*</a></div>
        </td>
        <td style="width: 2%; vertical-align: top; background-color: rgb(204, 238, 255);">&#160;</td>
        <td style="width: 88%; vertical-align: top; background-color: rgb(204, 238, 255);">
          <div>Equity Incentive Plan Rules.<br>
          </div>
        </td>
      </tr>
      <tr>
        <td style="width: 10%; vertical-align: top;" rowspan="1">&#160;</td>
        <td style="width: 2%; vertical-align: top;" rowspan="1">&#160;</td>
        <td style="width: 88%; vertical-align: top;" rowspan="1">&#160;</td>
      </tr>
      <tr>
        <td style="width: 10%; vertical-align: top; background-color: rgb(204, 238, 255);">
          <div><a href="ef20040301_ex99-2.htm">99.2*</a></div>
        </td>
        <td style="width: 2%; vertical-align: top; background-color: rgb(204, 238, 255);">&#160;</td>
        <td style="width: 88%; vertical-align: top; background-color: rgb(204, 238, 255);">
          <div>Telix Pharmaceuticals (US) Inc. Employee Stock Purchase Plan Rules.</div>
        </td>
      </tr>
      <tr>
        <td style="width: 10%; vertical-align: top;" rowspan="1">&#160;</td>
        <td style="width: 2%; vertical-align: top;" rowspan="1">&#160;</td>
        <td style="width: 88%; vertical-align: top;" rowspan="1">&#160;</td>
      </tr>
      <tr>
        <td style="width: 10%; vertical-align: top; background-color: rgb(204, 238, 255);">
          <div><a href="ef20040301_ex107.htm">107*</a></div>
        </td>
        <td style="width: 2%; vertical-align: top; background-color: rgb(204, 238, 255);">&#160;</td>
        <td style="width: 88%; vertical-align: top; background-color: rgb(204, 238, 255);">
          <div>Filing Fee Table.</div>
        </td>
      </tr>

  </table>
  <div> <br>
  </div>
  <div>* Filed herewith.</div>
  <div> <br>
  </div>
  <div>
    <hr noshade="noshade" align="left" style="background-color: #000000; border-bottom: medium none; border-left: medium none; border-right: medium none; border-top: medium none; margin: 0px auto 0px 0px; height: 2px; width: 8%; color: #000000;"></div>
  <div>&#160;</div>
  <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z81798a2f4aa94d0b9e5977de8ff3b97f">

      <tr>
        <td style="width: 36pt;"><br>
        </td>
        <td style="width: 36pt; vertical-align: top; font-weight: bold;">Item 9.</td>
        <td style="width: auto; vertical-align: top;">
          <div style="font-weight: bold;">Undertakings.</div>
        </td>
      </tr>

  </table>
  <div>&#160;</div>
  <div style="text-indent: 36pt;">1.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-style: italic;"><u>Item 512(a) of Regulation S-K</u></font>.&#160; The undersigned Registrant hereby undertakes:</div>
  <div>&#160;</div>
  <div style="text-indent: 36pt;">(1)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;To file, during any period in which offers or sales are being made, a post-effective amendment to this Registration Statement:</div>
  <div>&#160;</div>
  <div style="text-indent: 36pt; margin-left: 36pt;">(i)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;To include any prospectus required by Section 10(a)(3) of the Securities Act;</div>
  <div>&#160;</div>
  <div style="text-indent: 36pt; margin-left: 36pt;">(ii)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; To reflect in the prospectus any facts or events arising after the effective date of the registration statement (or the most recent post-effective amendment thereof) which, individually or
    in the aggregate, represent a fundamental change in the information set forth in the registration statement. Notwithstanding the foregoing, any increase or decrease in volume of securities offered (if the total dollar value of securities offered would
    not exceed that which was registered) and any deviation from the low or high end of the estimated maximum offering range may be reflected in the form of prospectus filed with the Commission pursuant to Rule 424(b) if, in the aggregate, the changes in
    volume and price represent no more than a 20% change in the maximum aggregate offering price set forth in the &#8220;Calculation of Filing Fee&#8221; table in the effective registration statement; and</div>
  <div>&#160;</div>
  <div style="text-indent: 36pt; margin-left: 36pt;">(iii)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; To include any material information with respect to the plan of distribution not previously disclosed in the registration statement or any material change to such information in the
    registration statement;</div>
  <div>&#160;</div>
  <div style="margin-left: 36pt;"><font style="font-style: italic;">provided, however,</font> that paragraphs (1)(i) and (1)(ii) do not apply if the registration statement is on Form S-8, and the information required to be included in a post-effective
    amendment by those paragraphs is contained in reports filed with or furnished to the Commission by the Registrant pursuant to Section 13 or Section 15(d) of the Exchange Act that are incorporated by reference in the registration statement.</div>
  <div>&#160;</div>
  <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
    <div style="page-break-after: always;" class="BRPFPageBreak">
      <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
  </div>
  <div style="text-indent: 36pt;">(2)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;That, for the purpose of determining any liability under the Securities Act, each such post-effective amendment shall be deemed to be a new registration statement relating to the securities offered therein,
    and the offering of such securities at that time shall be deemed to be the initial <font style="font-style: italic;">bona fide</font> offering thereof.</div>
  <div>&#160;</div>
  <div style="text-indent: 36pt;">(3)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;To remove from registration by means of a post-effective amendment any of the securities being registered which remain unsold at the termination of the offering.</div>
  <div>&#160;</div>
  <div style="text-indent: 36pt;">2.&#160;&#160;&#160;&#160;&#160;&#160;&#160; &#160;&#160; <font style="font-style: italic;"><u>Item 512(b) of Regulation S-K</u></font>.&#160; The undersigned Registrant hereby undertakes that, for purposes of determining any liability under the Securities Act, each
    filing of the Registrant&#8217;s annual report pursuant to Section 13(a) or Section 15(d) of the Exchange Act (and, where applicable, each filing of an employee benefit plan&#8217;s annual report pursuant to section 15(d) of the Exchange Act) that is incorporated
    by reference in the registration statement shall be deemed to be a new registration statement relating to the securities offered therein, and the offering of such securities at that time shall be deemed to be the initial <font style="font-style: italic;">bona fide</font> offering thereof.</div>
  <div>&#160;</div>
  <div style="text-indent: 36pt;">3.&#160;&#160;&#160;&#160;&#160;&#160; &#160; &#160; <font style="font-style: italic;"><u>Item 512(h) of Regulation S-K</u></font>.&#160; Insofar as indemnification for liabilities arising under the Securities Act may be permitted to directors, officers and
    controlling persons of the Registrant pursuant to the foregoing provisions, or otherwise, the Registrant has been advised that in the opinion of the Securities and Exchange Commission such indemnification is against public policy as expressed in the
    Securities Act and is, therefore, unenforceable. In the event that a claim for indemnification against such liabilities (other than the payment by the Registrant of expenses incurred or paid by a director, officer or controlling person of the
    Registrant in the successful defense of any action, suit or proceeding) is asserted by such director, officer or controlling person in connection with the securities being registered, the Registrant will, unless in the opinion of its counsel the matter
    has been settled by controlling precedent, submit to a court of appropriate jurisdiction the question whether such indemnification by it is against public policy as expressed in the Securities Act and will be governed by the final adjudication of such
    issue.</div>
  <div>&#160;</div>
  <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
    <div style="page-break-after: always;" class="BRPFPageBreak">
      <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
  </div>
  <div style="text-align: center; font-weight: bold;">SIGNATURES</div>
  <div>&#160;</div>
  <div style="text-indent: 36pt;">Pursuant to the requirements of the Securities Act of 1933, the Registrant certifies that it has reasonable grounds to believe that it meets all of the requirements for filing on Form S-8 and has duly caused this
    Registration Statement to be signed on its behalf by the undersigned, thereunto duly authorized, in Melbourne, Australia, on December 19, 2024.</div>
  <div>&#160;</div>
  <table cellspacing="0" cellpadding="0" border="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;" id="z9cdd42f18c734ae28ba77827b6ff7ddf">

      <tr>
        <td style="width: 50%; vertical-align: top;">&#160;</td>
        <td colspan="2" rowspan="1" style="width: 3%; vertical-align: top;">
          <div style="font-weight: bold;">Telix Pharmaceuticals Limited</div>
        </td>
      </tr>
      <tr>
        <td style="width: 50%; vertical-align: top;">&#160;</td>
        <td style="width: 3%; vertical-align: top;"><br>
        </td>
        <td style="width: 47%; vertical-align: top;"><br>
        </td>
      </tr>
      <tr>
        <td style="width: 50%; vertical-align: top; padding-bottom: 2px;">&#160;</td>
        <td style="width: 3%; vertical-align: top; padding-bottom: 2px;">
          <div>By:</div>
        </td>
        <td style="width: 47%; vertical-align: top; border-bottom: 2px solid rgb(0, 0, 0);">
          <div>/s/ Dr. Christian Behrenbruch</div>
        </td>
      </tr>
      <tr>
        <td style="width: 50%; vertical-align: top;">&#160;</td>
        <td style="width: 3%; vertical-align: top;">&#160;</td>
        <td style="width: 47%; vertical-align: top;">
          <div>Dr. Christian Behrenbruch</div>
        </td>
      </tr>
      <tr>
        <td style="width: 50%; vertical-align: top;">&#160;</td>
        <td style="width: 3%; vertical-align: top;">&#160;</td>
        <td style="width: 47%; vertical-align: top;">
          <div>Group Chief Executive Officer and Managing Director</div>
        </td>
      </tr>

  </table>
  <div><br>
  </div>
  <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
    <div style="page-break-after: always;" class="BRPFPageBreak">
      <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
  </div>
  <div style="text-align: center; font-weight: bold;"><a name="POWERSOFATTORNEYANDSIGNAT"><!--Anchor--></a>POWERS OF ATTORNEY AND SIGNATURES</div>
  <div>&#160;</div>
  <div style="text-indent: 36pt;"><font style="font-weight: bold;">KNOW ALL PERSONS BY THESE PRESENTS</font>, that each person whose signature appears below constitutes and appoints each of Christian Behrenbruch, Lena Moran-Adams and Darren Smith to act as
    his/her true and lawful attorney-in-fact and agent, with full power of substitution, for him/her and in his/her name, place and stead, in any and all such capacities, to sign any and all amendments, including post-effective amendments, and supplements
    to this Registration Statement, and to file the same, with all exhibits thereto and other documents in connection therewith, with the United States Securities and Exchange Commission, granting unto said attorney-in-fact and agent full power and
    authority to do and perform each and every act and thing requisite and necessary to be done in and about the premises, as fully to all intents and purposes as he/she might or could do in person, hereby ratifying and confirming all that said
    attorney-in-fact and agent, or his/her substitute or substitutes, may lawfully do or cause to be done by virtue hereof.</div>
  <div>&#160;</div>
  <div style="text-indent: 36pt;">Pursuant to the requirements of the Securities Act of 1933, as amended, this Registration Statement has been signed by the following persons in the capacities listed below, as of December 19, 2024.</div>
  <div>&#160;</div>
  <table cellspacing="0" cellpadding="0" border="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;" id="z762f6ef7e34a40fbac134a4ac1ae52df">

      <tr>
        <td style="width: 45%; vertical-align: top;">
          <div style="text-align: center; font-weight: bold;"><u>Signature</u></div>
        </td>
        <td style="width: 5%; vertical-align: top;" colspan="1"><br>
        </td>
        <td style="width: 50%; vertical-align: top;">
          <div style="text-align: center; font-weight: bold;"><u>Title</u></div>
        </td>
      </tr>
      <tr>
        <td rowspan="1" style="width: 45%; vertical-align: top;">&#160;</td>
        <td rowspan="1" style="width: 5%; vertical-align: top;" colspan="1"><br>
        </td>
        <td rowspan="1" style="width: 50%; vertical-align: top;">&#160;</td>
      </tr>
      <tr>
        <td style="width: 45%; vertical-align: middle; border-bottom: 2px solid rgb(0, 0, 0); text-align: center;">
          <div>/s/ Dr. Christian Behrenbruch</div>
        </td>
        <td style="width: 5%; vertical-align: top; padding-bottom: 2px;" colspan="1"><br>
        </td>
        <td style="width: 50%; vertical-align: middle; padding-bottom: 2px; text-align: center;">
          <div>Group Chief Executive Officer and Managing Director</div>
        </td>
      </tr>
      <tr>
        <td rowspan="1" style="width: 45%; vertical-align: middle; text-align: center;">
          <div>Dr. Christian Behrenbruch</div>
        </td>
        <td rowspan="1" style="width: 5%; vertical-align: top;" colspan="1"><br>
        </td>
        <td rowspan="1" style="width: 50%; vertical-align: middle; text-align: center;">
          <div>(<font style="font-style: italic;">Principal Executive Officer</font>)</div>
        </td>
      </tr>

  </table>
  <div><br>
  </div>
  <table cellspacing="0" cellpadding="0" border="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;">

      <tr>
        <td style="width: 45%; vertical-align: middle; border-bottom: 2px solid rgb(0, 0, 0); text-align: center;">
          <div>/s/ Darren Smith</div>
        </td>
        <td style="width: 5%; vertical-align: top; padding-bottom: 2px;" colspan="1"><br>
        </td>
        <td style="width: 50%; vertical-align: middle; padding-bottom: 2px; text-align: center;">
          <div>Group Chief Financial Officer</div>
        </td>
      </tr>
      <tr>
        <td rowspan="1" style="width: 45%; vertical-align: middle; text-align: center;">
          <div>Darren Smith</div>
        </td>
        <td rowspan="1" style="width: 5%; vertical-align: top;" colspan="1"><br>
        </td>
        <td rowspan="1" style="width: 50%; vertical-align: middle; text-align: center;">
          <div>(<font style="font-style: italic;">Principal Financial and Accounting Officer</font>)</div>
        </td>
      </tr>

  </table>
  <div><br>
  </div>
  <table cellspacing="0" cellpadding="0" border="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;">

      <tr>
        <td style="width: 45%; vertical-align: middle; border-bottom: 2px solid rgb(0, 0, 0); text-align: center;">
          <div>/s/ H Kevin McCann AO</div>
        </td>
        <td style="width: 5%; vertical-align: top; padding-bottom: 2px;" colspan="1"><br>
        </td>
        <td style="width: 50%; vertical-align: middle; text-align: center;" rowspan="2" colspan="1">
          <div>Director and Chairman</div>
        </td>
      </tr>
      <tr>
        <td rowspan="1" style="width: 45%; vertical-align: middle; text-align: center;">
          <div>H Kevin McCann AO</div>
        </td>
        <td rowspan="1" style="width: 5%; vertical-align: top;" colspan="1"><br>
        </td>
      </tr>

  </table>
  <div><br>
  </div>
  <table cellspacing="0" cellpadding="0" border="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;">

      <tr>
        <td style="width: 45%; vertical-align: middle; border-bottom: 2px solid rgb(0, 0, 0); text-align: center;">
          <div>/s/ Mark Nelson</div>
        </td>
        <td style="width: 5%; vertical-align: top; padding-bottom: 2px;" colspan="1"><br>
        </td>
        <td style="width: 50%; vertical-align: middle; text-align: center;" rowspan="2" colspan="1">
          <div>Director</div>
        </td>
      </tr>
      <tr>
        <td rowspan="1" style="width: 45%; vertical-align: middle; text-align: center;">
          <div>Mark Nelson</div>
        </td>
        <td rowspan="1" style="width: 5%; vertical-align: top;" colspan="1"><br>
        </td>
      </tr>

  </table>
  <div><br>
  </div>
  <table cellspacing="0" cellpadding="0" border="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;">

      <tr>
        <td style="width: 45%; vertical-align: middle; border-bottom: 2px solid rgb(0, 0, 0); text-align: center;">
          <div>/s/ Tiffany Olson</div>
        </td>
        <td style="width: 5%; vertical-align: top; padding-bottom: 2px;" colspan="1"><br>
        </td>
        <td style="width: 50%; vertical-align: middle; text-align: center;" rowspan="2" colspan="1">
          <div>Director</div>
        </td>
      </tr>
      <tr>
        <td rowspan="1" style="width: 45%; vertical-align: middle; text-align: center;">
          <div>Tiffany Olson</div>
        </td>
        <td rowspan="1" style="width: 5%; vertical-align: top;" colspan="1"><br>
        </td>
      </tr>

  </table>
  <div><br>
  </div>
  <table cellspacing="0" cellpadding="0" border="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;">

      <tr>
        <td style="width: 45%; vertical-align: middle; border-bottom: 2px solid rgb(0, 0, 0); text-align: center;">
          <div>/s/ Jann Skinner</div>
        </td>
        <td style="width: 5%; vertical-align: top; padding-bottom: 2px;" colspan="1"><br>
        </td>
        <td style="width: 50%; vertical-align: middle; text-align: center;" rowspan="2" colspan="1">
          <div>Director</div>
        </td>
      </tr>
      <tr>
        <td style="width: 45%; vertical-align: middle; text-align: center;" rowspan="1">
          <div>Jann Skinner</div>
        </td>
        <td style="width: 5%; vertical-align: top;" colspan="1" rowspan="1"><br>
        </td>
      </tr>

  </table>
  <div>&#160;</div>
  <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
    <div style="page-break-after: always;" class="BRPFPageBreak">
      <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
  </div>
  <div style="text-align: center; font-weight: bold;">Signature of Authorized Representative in the United States</div>
  <div>&#160;</div>
  <div style="text-indent: 36pt;">Pursuant to the requirements of the Securities Act of 1933, as amended, the undersigned, the duly authorized representative in the United States of Telix Pharmaceuticals Limited has signed this Registration Statement on
    December 19, 2024.</div>
  <div>&#160;</div>
  <table cellspacing="0" cellpadding="0" border="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;" id="zf5e39f919b1149d7a714af71605d1525">

      <tr>
        <td style="width: 50%; vertical-align: top;"><br>
        </td>
        <td colspan="2" rowspan="1" style="width: 3%; vertical-align: top;">
          <div>Telix Pharmaceuticals (US) Inc.</div>
        </td>
      </tr>
      <tr>
        <td style="width: 50%; vertical-align: top;"><br>
        </td>
        <td colspan="2" rowspan="1" style="width: 3%; vertical-align: top;">
          <div>Authorized Representative in the United States</div>
        </td>
      </tr>
      <tr>
        <td style="width: 50%; vertical-align: top;"><br>
        </td>
        <td style="width: 3%; vertical-align: top;">&#160;</td>
        <td style="width: 47%; vertical-align: top;"><br>
        </td>
      </tr>
      <tr>
        <td style="width: 50%; vertical-align: top; padding-bottom: 2px;"><br>
        </td>
        <td style="width: 3%; vertical-align: top; padding-bottom: 2px;">
          <div>By:</div>
        </td>
        <td style="width: 47%; vertical-align: top; border-bottom: 2px solid rgb(0, 0, 0);">
          <div>/s/ Christian Krautkramer</div>
        </td>
      </tr>
      <tr>
        <td style="width: 50%; vertical-align: top;"><br>
        </td>
        <td style="width: 3%; vertical-align: top;">&#160;</td>
        <td style="width: 47%; vertical-align: top;">
          <div>Name:&#160; Christian Krautkramer</div>
        </td>
      </tr>
      <tr>
        <td style="width: 50%; vertical-align: top;"><br>
        </td>
        <td style="width: 3%; vertical-align: top;">&#160;</td>
        <td style="width: 47%; vertical-align: top;">
          <div>Title:&#160; &#160; Group Deputy General Counsel</div>
        </td>
      </tr>

  </table>
  <div>&#160;</div>
  <div><br>
  </div>
  <hr noshade="noshade" align="center" style="height: 2px; color: #000000; background-color: #000000; text-align: center; margin-left: auto; margin-right: auto; border: none;">
</body>
</html>
[{"type": "S-8", "sequence": "1", "filename": "ef20040301_s8.htm", "description": "S-8", "secsgml_size_bytes": 53813}]
{"company-data": {"conformed-name": "Telix Pharmaceuticals Ltd", "cik": "0002007191", "assigned-sic": "2834", "organization-name": "03 Life Sciences", "irs-number": "000000000", "state-of-incorporation": "C3", "fiscal-year-end": "1231"}, "filing-values": {"form-type": "S-8", "act": "33", "file-number": "333-283917", "film-number": "241560916"}, "business-address": {"street1": "55 FLEMINGTON ROAD", "city": "NORTH MELBOURNE", "state": "C3", "zip": "3051", "phone": "61 3 9093 3855"}, "mail-address": {"street1": "55 FLEMINGTON ROAD", "city": "NORTH MELBOURNE", "state": "C3", "zip": "3051"}}
As filed with the Securities and Exchange Commission on December 19, 2024
Registration No. 333-
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C.  20549
FORM S-8
REGISTRATION STATEMENT UNDER
THE SECURITIES ACT OF 1933
Telix Pharmaceuticals Limited
(Exact Name of Registrant as Specified in Its Charter)
Australia
Not Applicable
(State or Other Jurisdiction of Incorporation or Organization)
(I.R.S. Employer Identification No.)
Telix Pharmaceuticals Limited
55 Flemington Road
North Melbourne, Victoria, 3051, Australia
Not Applicable
(Address of Principal Executive Offices)
(Zip Code)
Equity Incentive Plan Rules
Telix Pharmaceuticals (US) Inc. Employee Stock Purchase Plan Rules
(Full Title of the Plan)
Telix Pharmaceuticals (US) Inc.
11700 Exit 5 Pkwy, Suite 200
Fishers, Indiana 46037
Tel: (317) 588-9700
(Name, address, including zip code, and telephone number, including area code, of agent for service)
Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, smaller reporting company, or an emerging growth company. See the definitions of "large accelerated filer," "accelerated
    filer," "smaller reporting company," and "emerging growth company" in Rule 12b-2 of the Exchange Act.
Large accelerated filer  ☐
Accelerated filer  ☐
Non-accelerated filer  ☒
Smaller reporting company ☐
Emerging growth company  ☒
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 7(a)(2)(B) of the
    Securities Act. ☐
PART I
INFORMATION REQUIRED IN THE SECTION 10(a) PROSPECTUS
Item 1.
Plan Information.
The information required by Item 1 is included in documents sent or given to participants in the plans covered by this registration statement pursuant to Rule 428(b)(1) of the Securities Act of 1933, as amended (the
    "Securities Act").
Item 2.
Registrant Information and Employee Plan Annual Information.
The written statement required by Item 2 is included in documents sent or given to participants in the plans covered by this registration statement pursuant to Rule 428(b)(1) of the Securities Act.
PART II
INFORMATION REQUIRED IN THE REGISTRATION STATEMENT
Item 3.
Incorporation of Documents by Reference.
The Registrant is subject to the informational and reporting requirements of Sections 13(a), 14, and 15(d) of the Securities Exchange Act of 1934, as amended (the "Exchange Act") applicable to foreign private issuers, and
    in accordance therewith files reports and other information with the Securities and Exchange Commission (the "Commission").  The following documents, which are on file with the Commission, are incorporated in this registration statement ("Registration
    Statement") by reference:
(a)          The Registrant's effective registration statement on Form 20-F filed pursuant to Section 12 of the Exchange Act on
October 30, 2024
(File No. 001-42128), which contains the registrant's audited financial statements for the latest fiscal year for which such
    statements have been filed.
(b)          The description of the ordinary shares, no par value, and American Depositary Shares, each representing one ordinary share, no par value, contained in the Registrant's registration statement on Form 20-F filed
    pursuant to Section 12 of the Exchange Act on
October 30, 2024
(File No. 001-42128), including any amendment or report filed for the purpose of
    updating such description.
All documents subsequently filed by the Registrant pursuant to Sections 13(a), 13(c), 14 or 15(d) of the Exchange Act, prior to the filing of a post-effective amendment which indicates that all securities offered hereby
    have been sold or which deregisters all securities then remaining unsold, shall be deemed to be incorporated by reference in this Registration Statement and to be part hereof from the date of the filing of such documents.
Any statement contained in a document incorporated or deemed to be incorporated by reference herein shall be deemed to be modified or superseded for the purposes of this Registration Statement to the extent that a
    statement contained herein or in any other subsequently filed document which also is or is deemed to be incorporated by reference herein modifies or supersedes such statement.  Any statement so modified or superseded shall not be deemed, except as so
    modified or superseded, to constitute a part of this Registration Statement.
Item 4.
Description of Securities.
Not applicable.
Item 5.
Interests of Named Experts and Counsel.
Not applicable.
Item 6.
Indemnification of Directors and Officers.
Australian law
. Australian law provides that a company or a related body corporate of the company may provide for indemnification of officers and directors, except
    to the extent of any of the following liabilities incurred as an officer or director of the company:
•
a liability owed to the company or a related body corporate of the company;
•
a liability for a pecuniary penalty order made under section 1317G or a compensation order under section 961M, 1317H, 1317HA, 1317HB, 1317HC or 1317HE of the Australian Corporations Act;
•
a liability that is owed to someone other than the company or a related body corporate of the company and did not arise out of conduct in good faith; or
•
legal costs incurred in defending an action for a liability incurred as an officer or director of the company if the costs are incurred:
○
in defending or resisting proceedings in which the person is found to have a liability for which they cannot be indemnified as set out above;
○
in defending or resisting criminal proceedings in which the person is found guilty;
○
in defending or resisting proceedings brought by the Australian Securities & Investments Commission or a liquidator for a court order if the grounds for making the order are found by the court to have been
            established (except costs incurred in responding to actions taken by the Australian Securities & Investments Commission or a liquidator as part of an investigation before commencing proceedings for the court order); or
○
in connection with proceedings for relief to the person under the Australian Corporations Act, in which the court denies the relief.
Constitution
. The Registrant's Constitution provides that, except to the extent prohibited by the law including under the
      Australian Corporations Act, the Registrant must indemnify every person who is or has been a director, alternate director or executive officer of the
Registrant
and such other officers or former officers of
      the
Registrant
or of its related bodies corporate as the board of directors in each case determines against all losses, liabilities, costs, charges and expenses incurred by that person as an officer.
Indemnification and Insurance Agreements
. Pursuant to Deeds of Access, Insurance and Indemnity, the Registrant has agreed to indemnify the Registrant's executive
    officers and non-employee directors against certain liabilities and expenses incurred by such persons in connection with claims made by reason of their being such a director or officer. The Registrant also maintains insurance policies that indemnify
    the Registrant's directors and executive officers against various liabilities arising under the Securities Act or the Exchange Act, that might be incurred by any director or officer in his or her capacity as such. The underwriters are obligated, under
    certain circumstances, pursuant to the underwriting agreement, to indemnify the Registrant, the Registrant's officers and the Registrant's directors against liabilities under the Securities Act.
SEC Position
. Insofar as indemnification for liabilities arising under the Securities Act may be permitted to directors, officers or persons controlling the
    Registrant pursuant to the foregoing provisions, the Registrant has been informed that in the opinion of the SEC such indemnification is against public policy as expressed in the Securities Act and is therefore unenforceable.
Item 7.
Exemption from Registration Claimed.
Not applicable.
Item 8.
Exhibits.
Number
Description
4.1
Constitution of the Registrant (incorporated herein by reference to Exhibit 1.2 to the Registrant's Registration Statement on Form 20-F, filed on October 30, 2024 (File No. 001-42128)).
4.2
Deposit Agreement among the Registrant, JPMorgan Chase Bank, N.A., as depositary, and all Holders and Beneficial Owners of American depositary receipts issued thereunder (incorporated herein by reference to Exhibit 2.1 to the Registrant's
            Registration Statement on Form 20-F, filed on October 30, 2024 (File No. 001-42128)).
5.1*
Opinion of Herbert Smith Freehills.
23.1*
Consent of PricewaterhouseCoopers.
23.2*
Consent of Herbert Smith Freehills (included in Exhibit 5.1).
24.1*
Power of Attorney (included on the signature pages of this registration statement).
99.1*
Equity Incentive Plan Rules.
99.2*
Telix Pharmaceuticals (US) Inc. Employee Stock Purchase Plan Rules.
107*
Filing Fee Table.
* Filed herewith.
Item 9.
Undertakings.
1.
Item 512(a) of Regulation S-K
.  The undersigned Registrant hereby undertakes:
(1)          To file, during any period in which offers or sales are being made, a post-effective amendment to this Registration Statement:
(i)          To include any prospectus required by Section 10(a)(3) of the Securities Act;
(ii)         To reflect in the prospectus any facts or events arising after the effective date of the registration statement (or the most recent post-effective amendment thereof) which, individually or
    in the aggregate, represent a fundamental change in the information set forth in the registration statement. Notwithstanding the foregoing, any increase or decrease in volume of securities offered (if the total dollar value of securities offered would
    not exceed that which was registered) and any deviation from the low or high end of the estimated maximum offering range may be reflected in the form of prospectus filed with the Commission pursuant to Rule 424(b) if, in the aggregate, the changes in
    volume and price represent no more than a 20% change in the maximum aggregate offering price set forth in the "Calculation of Filing Fee" table in the effective registration statement; and
(iii)         To include any material information with respect to the plan of distribution not previously disclosed in the registration statement or any material change to such information in the
    registration statement;
provided, however,
that paragraphs (1)(i) and (1)(ii) do not apply if the registration statement is on Form S-8, and the information required to be included in a post-effective
    amendment by those paragraphs is contained in reports filed with or furnished to the Commission by the Registrant pursuant to Section 13 or Section 15(d) of the Exchange Act that are incorporated by reference in the registration statement.
(2)          That, for the purpose of determining any liability under the Securities Act, each such post-effective amendment shall be deemed to be a new registration statement relating to the securities offered therein,
    and the offering of such securities at that time shall be deemed to be the initial
bona fide
offering thereof.
(3)          To remove from registration by means of a post-effective amendment any of the securities being registered which remain unsold at the termination of the offering.
2.
Item 512(b) of Regulation S-K
.  The undersigned Registrant hereby undertakes that, for purposes of determining any liability under the Securities Act, each
    filing of the Registrant's annual report pursuant to Section 13(a) or Section 15(d) of the Exchange Act (and, where applicable, each filing of an employee benefit plan's annual report pursuant to section 15(d) of the Exchange Act) that is incorporated
    by reference in the registration statement shall be deemed to be a new registration statement relating to the securities offered therein, and the offering of such securities at that time shall be deemed to be the initial
bona fide
offering thereof.
3.
Item 512(h) of Regulation S-K
.  Insofar as indemnification for liabilities arising under the Securities Act may be permitted to directors, officers and
    controlling persons of the Registrant pursuant to the foregoing provisions, or otherwise, the Registrant has been advised that in the opinion of the Securities and Exchange Commission such indemnification is against public policy as expressed in the
    Securities Act and is, therefore, unenforceable. In the event that a claim for indemnification against such liabilities (other than the payment by the Registrant of expenses incurred or paid by a director, officer or controlling person of the
    Registrant in the successful defense of any action, suit or proceeding) is asserted by such director, officer or controlling person in connection with the securities being registered, the Registrant will, unless in the opinion of its counsel the matter
    has been settled by controlling precedent, submit to a court of appropriate jurisdiction the question whether such indemnification by it is against public policy as expressed in the Securities Act and will be governed by the final adjudication of such
    issue.
SIGNATURES
Pursuant to the requirements of the Securities Act of 1933, the Registrant certifies that it has reasonable grounds to believe that it meets all of the requirements for filing on Form S-8 and has duly caused this
    Registration Statement to be signed on its behalf by the undersigned, thereunto duly authorized, in Melbourne, Australia, on December 19, 2024.
Telix Pharmaceuticals Limited
By:
/s/ Dr. Christian Behrenbruch
Dr. Christian Behrenbruch
Group Chief Executive Officer and Managing Director
POWERS OF ATTORNEY AND SIGNATURES
KNOW ALL PERSONS BY THESE PRESENTS
, that each person whose signature appears below constitutes and appoints each of Christian Behrenbruch, Lena Moran-Adams and Darren Smith to act as
    his/her true and lawful attorney-in-fact and agent, with full power of substitution, for him/her and in his/her name, place and stead, in any and all such capacities, to sign any and all amendments, including post-effective amendments, and supplements
    to this Registration Statement, and to file the same, with all exhibits thereto and other documents in connection therewith, with the United States Securities and Exchange Commission, granting unto said attorney-in-fact and agent full power and
    authority to do and perform each and every act and thing requisite and necessary to be done in and about the premises, as fully to all intents and purposes as he/she might or could do in person, hereby ratifying and confirming all that said
    attorney-in-fact and agent, or his/her substitute or substitutes, may lawfully do or cause to be done by virtue hereof.
Pursuant to the requirements of the Securities Act of 1933, as amended, this Registration Statement has been signed by the following persons in the capacities listed below, as of December 19, 2024.
Signature
Title
/s/ Dr. Christian Behrenbruch
Group Chief Executive Officer and Managing Director
Dr. Christian Behrenbruch
(
Principal Executive Officer
)
/s/ Darren Smith
Group Chief Financial Officer
Darren Smith
(
Principal Financial and Accounting Officer
)
/s/ H Kevin McCann AO
Director and Chairman
H Kevin McCann AO
/s/ Mark Nelson
Director
Mark Nelson
/s/ Tiffany Olson
Director
Tiffany Olson
/s/ Jann Skinner
Director
Jann Skinner
Signature of Authorized Representative in the United States
Pursuant to the requirements of the Securities Act of 1933, as amended, the undersigned, the duly authorized representative in the United States of Telix Pharmaceuticals Limited has signed this Registration Statement on
    December 19, 2024.
Telix Pharmaceuticals (US) Inc.
Authorized Representative in the United States
By:
/s/ Christian Krautkramer
Name:  Christian Krautkramer
Title:    Group Deputy General Counsel